George Millen: Unscripted

With its CFO departing after a major strategic pivot, AAR CORP. names a 13-year insider as his interim replacement. What does this signal for investors?

The battery innovator secures fresh capital to scale its 'One-Pot' process. We analyze if this move signals a turning point for investors and the EV market.

Tile Shop is delisting from Nasdaq, forcing a cash-out for small investors. We analyze the high-stakes maneuver to save millions and what it signals.

A landmark deal creates Canada's largest private brokerage. We analyze the PE-backed strategy, the 'Canadian Champion' gambit, and what it means for the market.

LAMY's all-stock deal for Exousia AI is more than a merger; it's a strategic coup built on an early FDA designation for a novel brain cancer therapy.

Gelteq is pitching its innovative drug delivery gel to investors. But with a 'going concern' warning, can its promising tech secure the cash it needs to survive?

NextNRG's landmark FIU deal showcases next-gen EV charging, but can this high-stakes tech validation project power the company past its financial woes?

A breakthrough in Nevada could let Century Lithium produce both lithium and rare earths, reshaping its financial future and the North American supply chain.

GlobalTech Corp. acquires a majority stake in Moda in Pelle, aiming to inject its AI into the premium footwear market. A bold move or a risky bet?

Urbanfund Corp. just unlocked over $8M in capital by refinancing a Toronto asset. Here's what this savvy move signals about its growth plans and the market.

How did Pollard Banknote's subsidiary lock in a key Colorado Lottery contract? A 17% sales boost from digital tech proved its value.

Cadrenal Therapeutics appoints Dr. Lee Golden to its board, a strategic move signaling a push to accelerate its pipeline in a competitive market.

As ProQR prepares for its Evercore chat, investors weigh the promise of its unique RNA editing platform against a field of biotech giants.

A permit delay at a historic silver mine in Peru tests Carlton Precious, highlighting the clash between rich resources and tough environmental rules.

EnviroGold Global is deploying mobile pilot plants to unlock trillions in mine tailings. Is this strategic pivot the key to dominating the green metals race?

Karolinska Development seeks a massive capital injection, risking huge shareholder dilution to fund a promising drug pipeline and rebrand as KDventures.

Saba's BRW fund boasts a double-digit yield, but over half is a return of capital. We decode what this financial engineering means for investors.

A temporary mill shutdown at Conifex reveals the harsh reality of trade wars and a housing slump squeezing Canada's vital softwood lumber industry.

With 132% revenue growth and sustained profitability, Hydreight's platform strategy is rewriting the rules for at-home healthcare delivery and investment.

Pender Growth Fund reports a Q3 net loss, yet shareholder equity climbs. We dissect the numbers, the buybacks, and the strategy behind the contradiction.